aTyr Pharma Inc. (LIFE)
NASDAQ: LIFE
· Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 10:00 PM
aTyr Pharma Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2019 |
|---|---|---|---|
| Collaboration Revenue Revenue | 400K | 10M | 422K |
| Collaboration Revenue Revenue Growth | -96.00% | +2269.67% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.96M | 5.59M | 3.34M | 3.34M | 3.51M | 3.2M | 2.65M | 3.72M | 3.41M | 3.43M | 3.63M | 3.45M | 3.48M | 2.69M | 2.59M | 2.79M | 2.69M | 2.29M | 2.04M | 2.15M | 2.59M | 2.52M | 1.88M | 2.42M | 2.53M | 2.41M | 2.48M | 3.48M | 4.07M | 5.89M | 3.69M | 3.49M | 4.01M | 3.38M | 3.47M | 4.13M | 4.12M | 3.81M | 3.57M | 3.4M | 2.33M |
| Selling, General, and Administrative Revenue Growth | -29.23% | +67.69% | -0.18% | -4.70% | +9.46% | +20.95% | -28.75% | +9.10% | -0.53% | -5.49% | +5.10% | -0.95% | +29.68% | +3.67% | -7.17% | +3.87% | +17.04% | +12.28% | -4.75% | -17.14% | +2.94% | +33.62% | -22.22% | -4.38% | +4.89% | -2.46% | -28.80% | -14.59% | -30.90% | +59.45% | +5.94% | -12.98% | +18.45% | -2.51% | -15.90% | +0.27% | +7.92% | +6.69% | +5.24% | +45.81% | n/a |
| Research and Development Revenue | 11.81M | 17.93M | 14.81M | 13.97M | 13.36M | 12.76M | 10.32M | 9.84M | 9.38M | 14.91M | 9.87M | 9.13M | 8.9M | 5.96M | 5.14M | 7.66M | 4.52M | 4.7M | 4.62M | 4.36M | 3.62M | 3.59M | 3.8M | 3.31M | 3.35M | 3.55M | 4.2M | 6.48M | 6.15M | 5.31M | 7.13M | 8.42M | 9.2M | 9.14M | 10.39M | 11.31M | 12M | 12.67M | 7.74M | 7.5M | 6.59M |
| Research and Development Revenue Growth | -34.13% | +21.12% | +5.97% | +4.56% | +4.77% | +23.61% | +4.87% | +4.92% | -37.10% | +51.11% | +8.01% | +2.69% | +49.39% | +15.90% | -32.88% | +69.51% | -3.87% | +1.78% | +5.85% | +20.60% | +0.72% | -5.50% | +14.63% | -0.93% | -5.75% | -15.54% | -35.19% | +5.43% | +15.82% | -25.56% | -15.29% | -8.52% | +0.66% | -12.03% | -8.07% | -5.78% | -5.29% | +63.72% | +3.16% | +13.79% | n/a |